Innova Captab

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DUT01020
  • NSEID: INNOVACAP
  • BSEID: 544067
INR
939.75
4.35 (0.47%)
BSENSE

Jun 18

BSE+NSE Vol: 43.19 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Supriya Lifesci.
Innova Captab
Senores Pharma.
Bliss GVS Pharma
Advanced Enzyme
Sanofi India
FDC
Guj. Themis Bio.
Orchid Pharma
Aarti Pharma
Zota Health Care
Why is Innova Captab Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.35 times
2
Poor long term growth as Operating profit has grown by an annual rate 18.13% of over the last 5 years
3
Flat results in Mar 26
  • INTEREST(9M) At Rs 14.04 cr has Grown at 181.93%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 5.75 times
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 3.87 cr
4
Stock is technically in a Mildly Bullish range
  • The stocks MACD and KST technical factors are also Bullish
5
With ROCE of 13.9, it has a Very Attractive valuation with a 3.7 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -4.27%, its profits have risen by 9.9% ; the PEG ratio of the company is 3.5
6
High Institutional Holdings at 20.37%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Innova Captab should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Innova Captab for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Innova Captab
9.91%
-0.12
35.57%
Sensex
-4.95%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
22.78%
EBIT Growth (5y)
18.13%
EBIT to Interest (avg)
28.28
Debt to EBITDA (avg)
1.99
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
1.04
Tax Ratio
25.15%
Dividend Payout Ratio
8.12%
Pledged Shares
0
Institutional Holding
20.37%
ROCE (avg)
13.54%
ROE (avg)
13.14%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
38
Industry P/E
34
Price to Book Value
4.90
EV to EBIT
29.22
EV to EBITDA
23.68
EV to Capital Employed
4.06
EV to Sales
3.46
PEG Ratio
3.84
Dividend Yield
0.21%
ROCE (Latest)
13.91%
ROE (Latest)
12.92%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(Latest six months)

At Rs 898.09 cr has Grown at 42.28%

PAT(Latest six months)

At Rs 80.23 cr has Grown at 25.81%

PBT LESS OI(Q)

At Rs 49.12 cr has Grown at 20.4% (vs previous 4Q average

-7What is not working for the Company
INTEREST(9M)

At Rs 14.04 cr has Grown at 181.93%

INVENTORY TURNOVER RATIO(HY)

Lowest at 5.75 times

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 3.87 cr

Loading Valuation Snapshot...
Here's what is working for Innova Captab
Net Sales - Latest six months
At Rs 898.09 cr has Grown at 42.28%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Latest six months
At Rs 80.23 cr has Grown at 25.81%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 49.12 cr has Grown at 20.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 40.80 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for Innova Captab
Interest - Nine Monthly
At Rs 14.04 cr has Grown at 181.93%
over preceding nine months period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Inventory Turnover Ratio- Half Yearly
Lowest at 5.75 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 3.87 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents